GlassScriptPhysician profile
Peter S Nelson
NPI 1295926574
$6,883.60
in general payments reported to CMS, 2019-2025
19 companies · $961 in 2025
The $961 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,546 · 2020: $180 · 2021: $530 · 2022: $1,120 · 2023: $1,410 · 2024: $1,137 · 2025: $961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,312 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,311.62 |
| Education | $196.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,598.13 | 2019-2025 | Tremfya, Stelara, Simponi |
| Abbvie INC. | $1,435.63 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $740.12 | 2019-2022 | |
| Genzyme Corporation | $649.11 | 2019-2025 | |
| Amgen INC. | $485.64 | 2019-2024 | Otezla |
| Novartis Pharmaceuticals Corporation | $306.45 | 2019-2025 | |
| Celgene Corporation | $252.79 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $221.64 | 2024 | Sotyktu |
| Incyte Corporation | $219.28 | 2023-2025 | Opzelura, Opzelura |
| Almirall LLC | $135.67 | 2019 | |
| Lilly USA, LLC | $124.46 | 2020-2025 | Ebglyss |
| Ucb, INC. | $123.47 | 2019-2024 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $99.34 | 2023 | Dupixent |
| Pfizer INC. | $97.75 | 2024 | |
| Dermavant Sciences, INC. | $92.29 | 2023 | Vtama |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $91.85 | 2025 | Zoryve |
| Journey Medical Corporation | $72.44 | 2019 | |
| Epi Health, LLC | $71.40 | 2022 | |
| Sun Pharmaceutical Industries INC. | $66.14 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.